科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/10/26 | 3,343 | 3,354 | 3,297 | 3,318 | -16 | -0.5% | 100,800 |
| 2023/10/25 | 3,374 | 3,374 | 3,334 | 3,334 | -19 | -0.6% | 77,400 |
| 2023/10/24 | 3,333 | 3,363 | 3,301 | 3,353 | -8 | -0.2% | 80,300 |
| 2023/10/23 | 3,348 | 3,375 | 3,344 | 3,361 | +17 | +0.5% | 90,400 |
| 2023/10/20 | 3,327 | 3,357 | 3,313 | 3,344 | +17 | +0.5% | 88,200 |
| 2023/10/19 | 3,302 | 3,348 | 3,302 | 3,327 | -13 | -0.4% | 70,900 |
| 2023/10/18 | 3,328 | 3,348 | 3,300 | 3,340 | +22 | +0.7% | 102,700 |
| 2023/10/17 | 3,333 | 3,344 | 3,299 | 3,318 | -4 | -0.1% | 169,200 |
| 2023/10/16 | 3,346 | 3,369 | 3,312 | 3,322 | -24 | -0.7% | 180,400 |
| 2023/10/13 | 3,446 | 3,447 | 3,346 | 3,346 | -120 | -3.5% | 272,700 |
| 2023/10/12 | 3,460 | 3,484 | 3,450 | 3,466 | +2 | +0.1% | 138,100 |
| 2023/10/11 | 3,470 | 3,473 | 3,448 | 3,464 | -7 | -0.2% | 127,300 |
| 2023/10/10 | 3,471 | 3,482 | 3,465 | 3,471 | -2 | -0.1% | 147,500 |
| 2023/10/06 | 3,461 | 3,505 | 3,460 | 3,473 | +23 | +0.7% | 155,000 |
| 2023/10/05 | 3,455 | 3,477 | 3,437 | 3,450 | -23 | -0.7% | 226,900 |
| 2023/10/04 | 3,430 | 3,488 | 3,409 | 3,473 | +15 | +0.4% | 211,200 |
| 2023/10/03 | 3,470 | 3,480 | 3,432 | 3,458 | -12 | -0.3% | 208,600 |
| 2023/10/02 | 3,516 | 3,524 | 3,470 | 3,470 | -30 | -0.9% | 248,600 |
| 2023/09/29 | 3,515 | 3,524 | 3,492 | 3,500 | -23 | -0.7% | 234,900 |
| 2023/09/28 | 3,500 | 3,551 | 3,491 | 3,523 | -109 | -3% | 197,500 |
| 2023/09/27 | 3,591 | 3,633 | 3,570 | 3,632 | +30 | +0.8% | 271,400 |
| 2023/09/26 | 3,598 | 3,622 | 3,575 | 3,602 | +4 | +0.1% | 198,600 |
| 2023/09/25 | 3,575 | 3,610 | 3,570 | 3,598 | +30 | +0.8% | 163,500 |
| 2023/09/22 | 3,575 | 3,585 | 3,561 | 3,568 | -21 | -0.6% | 186,500 |
| 2023/09/21 | 3,617 | 3,625 | 3,582 | 3,589 | -17 | -0.5% | 159,100 |
| 2023/09/20 | 3,614 | 3,628 | 3,600 | 3,606 | -10 | -0.3% | 189,600 |
| 2023/09/19 | 3,647 | 3,654 | 3,602 | 3,616 | -21 | -0.6% | 202,600 |
| 2023/09/15 | 3,569 | 3,648 | 3,569 | 3,637 | -2 | -0.1% | 699,500 |
| 2023/09/14 | 3,600 | 3,640 | 3,573 | 3,639 | +47 | +1.3% | 236,200 |
| 2023/09/13 | 3,602 | 3,608 | 3,557 | 3,592 | -4 | -0.1% | 196,300 |
| 2023/09/12 | 3,561 | 3,614 | 3,557 | 3,596 | +45 | +1.3% | 170,400 |
| 2023/09/11 | 3,560 | 3,574 | 3,542 | 3,551 | -18 | -0.5% | 150,600 |
| 2023/09/08 | 3,551 | 3,579 | 3,543 | 3,569 | +18 | +0.5% | 156,600 |
| 2023/09/07 | 3,560 | 3,565 | 3,541 | 3,551 | -11 | -0.3% | 168,300 |
| 2023/09/06 | 3,565 | 3,565 | 3,533 | 3,562 | +2 | +0.1% | 180,900 |
| 2023/09/05 | 3,577 | 3,577 | 3,546 | 3,560 | -17 | -0.5% | 148,400 |
| 2023/09/04 | 3,575 | 3,585 | 3,551 | 3,577 | +4 | +0.1% | 109,600 |
| 2023/09/01 | 3,560 | 3,586 | 3,535 | 3,573 | -7 | -0.2% | 162,300 |
| 2023/08/31 | 3,573 | 3,602 | 3,544 | 3,580 | +4 | +0.1% | 162,200 |
| 2023/08/30 | 3,548 | 3,591 | 3,543 | 3,576 | +23 | +0.6% | 427,300 |
| 2023/08/29 | 3,550 | 3,553 | 3,515 | 3,553 | -1 | ±0% | 256,700 |
| 2023/08/28 | 3,568 | 3,578 | 3,554 | 3,554 | -2 | -0.1% | 81,900 |
| 2023/08/25 | 3,556 | 3,574 | 3,550 | 3,556 | +8 | +0.2% | 86,700 |
| 2023/08/24 | 3,520 | 3,555 | 3,512 | 3,548 | ±0 | ±0% | 81,700 |
| 2023/08/23 | 3,535 | 3,554 | 3,530 | 3,548 | -9 | -0.3% | 72,800 |
| 2023/08/22 | 3,544 | 3,565 | 3,523 | 3,557 | +13 | +0.4% | 80,800 |
| 2023/08/21 | 3,555 | 3,580 | 3,523 | 3,544 | -3 | -0.1% | 153,500 |
| 2023/08/18 | 3,506 | 3,566 | 3,504 | 3,547 | +25 | +0.7% | 144,700 |
| 2023/08/17 | 3,575 | 3,575 | 3,510 | 3,522 | -47 | -1.3% | 188,600 |
| 2023/08/16 | 3,556 | 3,582 | 3,541 | 3,569 | -12 | -0.3% | 105,700 |
401～
450
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
